Skip to main content

Advertisement

Log in

Impact of directional coronary atherectomy followed by drug-coated balloon strategy to avoid the complex stenting for bifurcation lesions

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Although the simple single stenting rather than complex double stenting is recommended on percutaneous coronary intervention (PCI) for bifurcation lesions, double stenting cannot always be avoided. We investigated the impact of directional coronary atherectomy (DCA), followed by drug-coated balloon (DCB) treatment to reduce the number of stents and avoid complex stenting in PCI for bifurcation lesions and short-term patency. DCA treatment without stents was attempted for 27 bifurcation lesions in 25 patients, of those, 26 bifurcation lesions in 24 patients were successfully treated and 3-month follow-up angiography and optical coherence tomography (OCT) were performed. Sixteen lesions (59.3%) were related to left main trunk distal bifurcations, and 7 (25.9%) were true bifurcation lesions. Among the true bifurcation lesions, 4 lesions (57.1%) needed 1 stent, and the other 3 lesions (42.9%) needed no stents. Among the non-true bifurcation lesions, 1 lesion (5.0%) needed bailout stent and other lesions (95.0%) needed no stents. According to DCA followed by DCB treatment, the angiographic mean diameter stenosis improved from 65.5 ± 15.0% to 7.8 ± 9.8%, and the mean plaque area in intravascular ultrasound improved from 80.4 ± 10.5% to 39.0 ± 11.5%, respectively. Angiographic and OCT late lumen loss values were 0.2 ± 0.6 mm and 1.4 ± 1.9 mm, respectively. No patient had in-hospital major adverse cardiac events (MACE) and 3-month MACE. In conclusion, compared with standard provisional side branch stenting strategy, DCA followed by DCB treatment might reduce the number of stents, avoid complex stenting for major bifurcation lesions and provide good short-term outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lassen JF, Holm NR, Banning A, Burzotta F, Lefèvre T, Chieffo A, Hildick-Smith D, Louvard Y, Stankovic G (2016) Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club. EuroIntervention 12:38–46

    Article  PubMed  Google Scholar 

  2. Banning AP, Lassen JF, Burzotta F, Lefèvre T, Darremont O, Hildick-Smith D, Louvard Y, Stankovic G (2019) Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European Bifurcation Club. EuroIntervention 15:90–98

    Article  PubMed  Google Scholar 

  3. Fujino Y, Attizzani GF, Tahara S, Naganuma T, Takagi K, Yabushita H, Wang W, Tanaka K, Matsumoto T, Kawamoto H, Yamada Y, Amano S, Watanabe Y, Warisawa T, Sato T, Mitomo S, Kurita N, Ishiguro H, Hozawa K, Tsukahara T, Motosuke M, Bezerra HG, Nakamura S, Nakamura S (2017) Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography. Int J Cardiol 230:284–292

    Article  PubMed  Google Scholar 

  4. Kume T, Yamada R, Terumasa K, Tamada T, Imai K, Fukuhara K, Goryo Y, Kawamura A, Hiroshi O, Neishi Y, Uemura S (2018) Neointimal coverage of jailed side branches in coronary bifurcation lesions: an optical coherence tomography analysis. Coron Artery Dis 29:114–118

    Article  PubMed  Google Scholar 

  5. Kim YH, Lee JH, Roh JH, Ahn JM, Yoon SH, Park DW, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Seung KB, Shin WY, Lee NH, Lee BK, Lee SG, Nam CW, Yoon J, Yang JY, Hyon MS, Lee K, Jang JS, Kim HS, Park SW, Park SJ (2015) Randomized comparisons between different stenting approaches for bifurcation coronary lesions with or without side branch stenosis. JACC Cardiovasc Interv 8:550–560

    Article  PubMed  Google Scholar 

  6. Lee CH, Choi SW, Hwang J, Kim IC, Cho YK, Park HS, Yoon HJ, Kim H, Han S, Kim JY, Lee JM, Doh JH, Shin ES, Koo BK, Hur SH, Nam CW (2019) 5-year outcomes according to FFR of left circumflex coronary artery after left main crossover stenting. JACC Cardiovasc Interv 12:847–855

    Article  PubMed  Google Scholar 

  7. Dauerman HL, Higgins PJ, Sparano AM, Gibson CM, Garber GR, Carrozza JP Jr, Kuntz RE, Laham RJ, Shubrooks SJ Jr, Baim DS, Cohen DJ (1998) Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions. J Am Coll Cardiol 32:1845–1852

    Article  CAS  PubMed  Google Scholar 

  8. Suzuki T, Hosokawa H, Katoh O, Fujita T, Ueno K, Takase S, Fujii K, Tamai H, Aizawa T, Yamaguchi T, Kurogane H, Kijima M, Oda H, Tsuchikane E, Hinohara T, Fitzgerald PJ (1999) Effects of adjunctive balloon angioplasty after intravascular ultrasound-guided optimal directional coronary atherectomy: the result of Adjunctive Balloon Angioplasty After Coronary Atherectomy Study (ABACAS). J Am Coll Cardiol 34:1028–1035

    Article  CAS  PubMed  Google Scholar 

  9. Baim DS, Cutlip DE, Sharma SK, Ho KK, Fortuna R, Schreiber TL, Feldman RL, Shani J, Senerchia C, Zhang Y, Lansky AJ, Popma JJ, Kuntz RE (1998) Final results of the balloon vs optimal atherectomy trial (BOAT). Circulation 97:322–331

    Article  CAS  PubMed  Google Scholar 

  10. Tsuchikane E, Sumitsuji S, Awata N, Nakamura T, Kobayashi T, Izumi M, Otsuji S, Tateyama H, Sakurai M, Kobayashi T (1999) Final results of the stent versus directional coronary atherectomy randomized trial (START). J Am Coll Cardiol 34:1050–1057

    Article  CAS  PubMed  Google Scholar 

  11. Simonton CA, Leon MB, Baim DS, Hinohara T, Kent KM, Bersin RM, Wilson BH, Mintz GS, Fitzgerald PJ, Yock PG, Popma JJ, Ho KK, Cutlip DE, Senerchia C, Kuntz RE (1998) “Optimal” directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). Circulation 97:332–339

    Article  CAS  PubMed  Google Scholar 

  12. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK, Kim JJ, Mintz GS, Park SW (2005) Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45:351–356

    Article  CAS  PubMed  Google Scholar 

  13. Valgimigli M, van Mieghem CA, Ong AT, Aoki J, Granillo GA, McFadden EP, Kappetein AP, de Feyter PJ, Smits PC, Regar E, Van der Giessen WJ, Sianos G, de Jaegere P, Van Domburg RT, Serruys PW (2005) Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation 111:1383–1389

    Article  PubMed  Google Scholar 

  14. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B (2010) Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 99:165–174

    Article  CAS  PubMed  Google Scholar 

  15. Zeymer U, Waliszewski M, Spiecker M, Gastmann O, Faurie B, Ferrari M, Alidoosti M, Palmieri C, Heang TN, Ong PJ, Dietz U (2014) Prospective “real world” registry for the use of the “PCB only” strategy in small vessel de novo lesions. Heart 100:311–316

    Article  CAS  PubMed  Google Scholar 

  16. Megaly M, Rofael M, Saad M, Rezq A, Kohl LP, Kalra A, Shishehbor M, Soukas P, Abbott JD, Brilakis ES (2019) Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc Interv 93:E277–E286

    Article  PubMed  Google Scholar 

  17. Cortese B, di Palma G, Latini RA, Elwany M, Orrego PS, Seregni RG (2017) Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry. Cardiovasc Revasc Med 18:487–491

    Article  PubMed  Google Scholar 

  18. Iwasaki Y, Koike J, Ko T, Funatsu A, Kobayashi T, Ikeda T, Nakamura S (2021) Comparison of drug-eluting stents vs. drug-coated balloon after rotational atherectomy for severely calcified lesions of nonsmall vessels. Heart Vessels 36:189–199

    Article  PubMed  Google Scholar 

  19. Sato A, Kijima M, Ichimura S, Yaegashi D, Anzai F, Shimizu T, Matsui Y, Kaneko H, Sakamoto K, Seino Y, Maruyama Y, Takeishi Y (2019) Short-term outcome of percutaneous coronary intervention with directional coronary atherectomy followed by drug-coated balloon: a preliminary report. Cardiovasc Interv Ther 34:149–154

    Article  CAS  PubMed  Google Scholar 

  20. Kobayashi N, Yamawaki M, Mori S, Tsutsumi M, Honda Y, Makino K, Shirai S, Mizusawa M, Ito Y (2021) Stentless strategy by drug-coated balloon angioplasty following directional coronary atherectomy for left main bifurcation lesion. J Interv Cardiol 2021:5529317

    PubMed  PubMed Central  Google Scholar 

  21. Louvard Y, Medina A (2015) Definitions and classifications of bifurcation lesions and treatment. EuroIntervention 11(Suppl V):23–26

    Article  Google Scholar 

  22. Habara M, Tsuchikane E, Nasu K, Kinoshita Y, Yaguchi T, Suzuki Y, Matsuo H, Terashima M, Matsubara T, Suzuki T (2017) The first clinical experience with a novel directional coronary atherectomy catheter: preliminary Japanese multicenter experience. Catheter Cardiovasc Interv 89:880–887

    Article  PubMed  Google Scholar 

  23. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction (2018) Fourth universal definition of myocardial infarction. J Am Coll Cardiol 72:2231–2264

    Article  PubMed  Google Scholar 

  24. Park TK, Park YH, Song YB, Oh JH, Chun WJ, Kang GH, Jang WJ, Hahn JY, Yang JH, Choi SH, Choi JH, Lee SH, Jeong MH, Kim HS, Lee JH, Yu CW, Rha SW, Jang Y, Yoon JH, Tahk SJ, Seung KB, Park JS, Gwon HC (2015) Long-term clinical outcomes of true and non-true bifurcation lesions according to medina classification—results from the COBIS (COronary BIfurcation Stent) II Registry. Circ J 79:1954–1962

    Article  PubMed  Google Scholar 

  25. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemelä M, Kervinen K, Jensen JS, Galløe A, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L, Nordic PCI Study Group (2006) Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation 114:1955–1961

    Article  PubMed  Google Scholar 

  26. Costopoulos C, Latib A, Ferrarello S, Naganuma T, Sticchi A, Filippo F, Giannini F, Basavarajaiah S, Kawaguchi M, Naim C, Candreva A, Carlino M, Chieffo A, Montorfano M, Colombo A (2013) First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations. Cardiovasc Revasc Med 14:311–315

    Article  PubMed  Google Scholar 

  27. Lee JM, Hahn JY, Kang J, Park KW, Chun WJ, Rha SW, Yu CW, Jeong JO, Jeong MH, Yoon JH, Jang Y, Tahk SJ, Gwon HC, Koo BK, Kim HS (2015) Differential prognostic effect between first- and second-generation drug-eluting stents in coronary bifurcation lesions: patient-level analysis of the Korean bifurcation pooled cohorts. JACC Cardiovasc Interv 8:1318–1331

    Article  PubMed  Google Scholar 

  28. Cho Y, Koo BK, Song YB, Hahn JY, Choi SH, Gwon HC, Rha SW, Yu CW, Park JS, Bae JH, Lee JH, Jeong MH, Yoon JH, Jang Y, Kim HS (2015) Comparison of the first- and second-generation limus-eluting stents for bifurcation lesions from a Korean multicenter registry. Circ J 79:544–552

    Article  PubMed  Google Scholar 

  29. Katritsis DG, Siontis GC, Ioannidis JP (2009) Double versus single stenting for coronary bifurcation lesions: a meta-analysis. Circ Cardiovasc Interv 2:409–415

    Article  PubMed  Google Scholar 

  30. Song YB, Hahn JY, Yang JH, Choi SH, Choi JH, Lee SH, Jeong MH, Kim HS, Lee JH, Yu CW, Rha SW, Jang Y, Yoon JH, Tahk SJ, Seung KB, Oh JH, Park JS, Gwon HC (2014) Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II. JACC Cardiovasc Interv 7:255–263

    Article  PubMed  Google Scholar 

  31. Maeng M, Holm NR, Erglis A, Kumsars I, Niemelä M, Kervinen K, Jensen JS, Galløe A, Steigen TK, Wiseth R, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Christiansen EH, Lassen JF, Thuesen L, Nordic-Baltic Percutaneous Coronary Intervention Study Group (2013) Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results. J Am Coll Cardiol 62:30–34

    Article  PubMed  Google Scholar 

  32. Behan MW, Holm NR, de Belder AJ, Cockburn J, Erglis A, Curzen NP, Niemelä M, Oldroyd KG, Kervinen K, Kumsars I, Gunnes P, Stables RH, Maeng M, Ravkilde J, Jensen JS, Christiansen EH, Cooter N, Steigen TK, Vikman S, Thuesen L, Lassen JF, Hildick-Smith D (2016) Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Eur Heart J 37:1923–1928

    Article  PubMed  Google Scholar 

  33. Zimarino M, Barbato E, Nakamura S, Radico F, Di Nicola M, Briguori C, Gil RJ, Kanic V, Perfetti M, Pellicano M, Mairic K, Stankovic G, Club EB (2020) The impact of the extent of side branch disease on outcomes following bifurcation stenting. Catheter Cardiovasc Interv 96:E84–E92

    Article  PubMed  Google Scholar 

  34. Perl L, Witberg G, Greenberg G, Vaknin-Assa H, Kornowski R, Assali A (2020) Prognostic significance of the Medina classification in bifurcation lesion percutaneous coronary intervention with second-generation drug-eluting stents. Heart Vessels 35:331–339

    Article  PubMed  Google Scholar 

  35. Worthley S, Hendriks R, Worthley M, Whelan A, Walters DL, Whitbourn R, Meredith I (2015) Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study. Cardiovasc Revasc Med 16:413–417

    Article  PubMed  Google Scholar 

  36. Berland J, Lefèvre T, Brenot P, Fajadet J, Motreff P, Guerin P, Dupouy P, Schandrin C, DEBSIDE Trial Investigators (2015) DANUBIO—a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial. EuroIntervention 11:868–876

    Article  PubMed  Google Scholar 

  37. Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S, Limbruno U (2010) Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 96:1291–1296

    Article  PubMed  Google Scholar 

  38. Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A, Tespili M, Presbitero P, Sgueglia GA, Buffoli F, Tamburino C, Varbella F, Menozzi A (2012) A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol 60:2473–2480

    Article  CAS  PubMed  Google Scholar 

  39. Jeger RV, Farah A, Ohlow MA, Mangner N, Möbius-Winkler S, Leibundgut G, Weilenmann D, Wöhrle J, Richter S, Schreiber M, Mahfoud F, Linke A, Stephan FP, Mueller C, Rickenbacher P, Coslovsky M, Gilgen N, Osswald S, Kaiser C, Scheller B, BASKET-SMALL 2 Investigators (2018) Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 392:849–856

    Article  CAS  PubMed  Google Scholar 

  40. Tanaka A, Jabbour RJ, Kawamoto H, Mangieri A, Pagnesi M, Montalto C, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo A (2016) Preliminary report of clinical outcomes after single crossover bioresorbable scaffold implantation without routine side branch strut dilation. Catheter Cardiovasc Interv 88:865–870

    Article  PubMed  Google Scholar 

  41. Kawamoto H, Latib A, Ruparelia N, Miyazaki T, Sticchi A, Naganuma T, Sato K, Figini F, Chieffo A, Carlino M, Montorfano M, Colombo A (2015) Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy. Catheter Cardiovasc Interv 86:644–652

    Article  PubMed  Google Scholar 

  42. Naganuma T, Colombo A, Lesiak M, Capodanno D, Gori T, Nef H, Caramanno G, Naber C, Di Mario C, Ruparelia N, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Kawamoto H, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Latib A (2017) Bioresorbable vascular scaffold use for coronary bifurcation lesions: a substudy from GHOST EU registry. Catheter Cardiovasc Interv 89:47–56

    Article  PubMed  Google Scholar 

  43. Kawamoto H, Ruparelia N, Tanaka A, Chieffo A, Latib A, Colombo A (2016) Bioresorbable scaffolds for the management of coronary bifurcation lesions. JACC Cardiovasc Interv 9:989–100

    Article  PubMed  Google Scholar 

  44. Stone GW, Abizaid A, Onuma Y, Seth A, Gao R, Ormiston J, Kimura T, Chevalier B, Ben-Yehuda O, Dressler O, McAndrew T, Ellis SG, Kereiakes DJ, Serruys PW (2017) Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials. J Am Coll Cardiol 70:2863–2874

    Article  PubMed  Google Scholar 

  45. Tanaka A, Latib A, Kawamoto H, Jabbour RJ, Mangieri A, Pagnesi M, Montalto C, Regazzoli D, Ancona M, Chieffo A, Carlino M, Montorfano M, Colombo A (2016) Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds. Catheter Cardiovasc Interv 88:854–862

    Article  PubMed  Google Scholar 

  46. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, Masden RR, Serruys PW, Leon MB, Williams DO, King SB, Mark DB, Isner JM, Holmes DR, Ellis SG, Lee KL, Keeler GP, Berdan LG, Hinohara T, Califf RM, for the CAVEAT Study Group (1993) A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 329:221–217

    Article  CAS  PubMed  Google Scholar 

  47. Adelman AG, Cohen EA, Kimball BP, Bonan R, Ricci DR, Webb JG, Laramee L, Barbeau G, Traboulsi M, Corbett BN, Schwartz L, Logan AG (1993) A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med 329:228–233

    Article  CAS  PubMed  Google Scholar 

  48. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R, RAVEL Study Group (2002) Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780

    Article  CAS  PubMed  Google Scholar 

  49. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, SIRIUS Investigators (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323

    Article  CAS  PubMed  Google Scholar 

  50. Goel SS, Dilip Gajulapalli R, Athappan G, Philip F, Gupta S, Murat Tuzcu E, Ellis SG, Mishkel G, Kapadia SR (2016) Management of drug eluting stent in-stent restenosis: a systematic review and meta-analysis. Catheter Cardiovasc Interv 87:1080–1091

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaaki Okutsu.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okutsu, M., Mitomo, S., Ouchi, T. et al. Impact of directional coronary atherectomy followed by drug-coated balloon strategy to avoid the complex stenting for bifurcation lesions. Heart Vessels 37, 919–930 (2022). https://doi.org/10.1007/s00380-021-02000-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-021-02000-z

Keywords

Navigation